Source:http://linkedlifedata.com/resource/pubmed/id/19954476
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-12-3
|
pubmed:abstractText |
Capillary permeability is a tightly regulated feature of microcirculation in all organ beds; however, in sepsis this feature is fundamentally altered. We previously reported elevated levels of vascular endothelial growth factor and its receptor (fms-like tyrosine kinase-1) in patients with septic shock, then investigated two kinds of angiopoietins in those patients. An enzyme-linked immunoassay was used to measure serum angiopoietin-1 and -2 levels in 12 patients with septic shock who were treated by direct hemoperfusion with a polymyxin B-immobilized fiber column (DHP-PMX). The angiopoietin-1 level was lower in patients with septic shock (7.01 +/- 10.08 ng/mL) than in controls (28.24 +/- 11.61 ng/mL, P < 0.001), but the angiopoietin-2 level was higher in septic shock patients (40.83 +/- 30.13 ng/mL vs. 2.47 +/- 1.78 ng/mL, P < 0.001). Between seven survivors and five non-survivors there was no significant difference in angiopoietin-1 levels before DHP-PMX therapy. During DHP-PMX therapy, however, the angiopoietin-2 level was significantly decreased in survivors (31.52 +/- 26.15 ng/mL vs. 17.32 +/- 22.46 ng/mL, P = 0.035). Moreover, at the end of the therapy, the angiopoietin-1 level was significantly lower in non-survivors (1.14 +/- 1.30 ng/mL vs. 10.43 +/- 13.56 ng/mL, P = 0.042), but the angiopoietin-2 level in non-survivors was significantly higher (70.79 +/- 40.47 ng/mL vs. 17.32 +/- 22.46 ng/mL, P = 0.019). The angiopoietin-2 level may be associated with vascular permeability in septic patients, and angiopoietins may be suitable markers of disease severity and mortality.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ANGPT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Angiopoietin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Angiopoietin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Polymyxin B
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1744-9987
|
pubmed:author |
pubmed-author:EbiharaItaruI,
pubmed-author:FujitaShogoS,
pubmed-author:HirayamaKouichiK,
pubmed-author:KaiHirayasuH,
pubmed-author:KakitaTomokoT,
pubmed-author:KobayashiMasakiM,
pubmed-author:MiyamotoYasunoriY,
pubmed-author:NagaiKeiK,
pubmed-author:NagaiMihoM,
pubmed-author:OgawaYujiroY,
pubmed-author:ShimohataHomareH,
pubmed-author:UsuiJoichiJ,
pubmed-author:YamagataKunihiroK
|
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
520-7
|
pubmed:meshHeading |
pubmed-meshheading:19954476-Aged,
pubmed-meshheading:19954476-Aged, 80 and over,
pubmed-meshheading:19954476-Angiopoietin-1,
pubmed-meshheading:19954476-Angiopoietin-2,
pubmed-meshheading:19954476-Biological Markers,
pubmed-meshheading:19954476-Capillary Permeability,
pubmed-meshheading:19954476-Case-Control Studies,
pubmed-meshheading:19954476-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19954476-Female,
pubmed-meshheading:19954476-Hemoperfusion,
pubmed-meshheading:19954476-Humans,
pubmed-meshheading:19954476-Male,
pubmed-meshheading:19954476-Middle Aged,
pubmed-meshheading:19954476-Polymyxin B,
pubmed-meshheading:19954476-Severity of Illness Index,
pubmed-meshheading:19954476-Shock, Septic,
pubmed-meshheading:19954476-Survivors
|
pubmed:year |
2009
|
pubmed:articleTitle |
Angiopoietin balance in septic shock patients treated by direct hemoperfusion with polymyxin b-immobilized fiber.
|
pubmed:affiliation |
Department of Nephrology, Mito Saiseikai General Hospital, Mito, Ibaraki, Japan. itaruebi@yahoo.co.jp
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|